Abstract
Natural killer (NK) cells and interferon (IFN)-γ have been implicated in immune surveillance against tumor development. Here we show that tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) plays a critical role in the NK cell–mediated and IFN-γ–dependent tumor surveillance. Administration of neutralizing monoclonal antibody against TRAIL promoted tumor development in mice subcutaneously inoculated with a chemical carcinogen methylcholanthrene (MCA). This protective effect of TRAIL was at least partly mediated by NK cells and totally dependent on IFN-γ. In the absence of TRAIL, NK cells, or IFN-γ, TRAIL-sensitive sarcomas preferentially emerged in MCA-inoculated mice. Moreover, development of spontaneous tumors in p53+/− mice was also promoted by neutralization of TRAIL. These results indicated a substantial role of TRAIL as an effector molecule that eliminates developing tumors.
References
39
Referenced
340
10.1038/86297
/ Nat. Immunol. (2001)10.1038/319675a0
/ Nature. (1986)10.1016/S0065-2776(08)60664-1
/ Adv. Immunol. (1989)10.1093/intimm/13.4.459
/ Int. Immunol. (2001)10.1084/jem.191.4.661
/ J. Exp. Med. (2000)10.1002/(SICI)1521-4141(199904)29:04<1390::AID-IMMU1390>3.0.CO;2-C
/ Eur. J. Immunol. (1999)10.1006/smim.1995.0012
/ Semin. Immunol. (1995)10.1182/blood.V97.1.192
/ Blood. (2001)10.1146/annurev.immunol.15.1.749
/ Annu. Rev. Immunol. (1997)10.1016/1074-7613(94)90087-6
/ Immunity. (1994)10.3109/10428199809050906
/ Leuk. Lymphoma. (1998)10.1084/jem.182.1.155
/ J. Exp. Med. (1995)10.1002/jlb.61.3.246
/ J. Leukoc. Biol. (1997)10.1038/376596a0
/ Nature. (1995)10.1182/blood.V93.10.3309.410k04_3309_3316
/ Blood. (1999)10.1038/83416
/ Nat. Med. (2001)10.1084/jem.193.6.661
/ J. Exp. Med. (2001)10.1016/1074-7613(95)90057-8
/ Immunity. (1995)10.1074/jbc.271.22.12687
/ J. Biol. Chem. (1996)10.1038/5517
/ Nat. Med. (1999)10.1172/JCI6926
/ J. Clin. Invest. (1999)10.4049/jimmunol.163.4.1906
/ J. Immunol. (1999)10.1073/pnas.95.13.7556
/ Proc. Natl. Acad. Sci. USA. (1998)10.1016/S0960-9822(00)00002-6
/ Curr. Biol. (1994)10.1084/jem.192.5.755
/ J. Exp. Med. (2000)10.1084/jem.191.7.1095
/ J. Exp. Med. (2000)10.4049/jimmunol.166.2.1314
/ J. Immunol. (2001)10.1084/jem.189.8.1343
/ J. Exp. Med. (1999)10.1084/jem.190.8.1155
/ J. Exp. Med. (1999)10.1084/jem.184.5.1781
/ J. Exp. Med. (1996){'key': '2023072511264624500_BIB31', 'first-page': '2770', 'volume': '59', 'year': '1999', 'journal-title': 'Cancer Res.'}
/ Cancer Res. (1999){'key': '2023072511264624500_BIB32', 'first-page': '1593', 'volume': '58', 'year': '1998', 'journal-title': 'Cancer Res.'}
/ Cancer Res. (1998)10.1038/ng1097-141
/ Nat. Genet. (1997)10.1126/science.281.5381.1305
/ Science. (1998)10.1016/S0960-9822(06)90000-1
/ Curr. Biol. (1997)10.1038/386517a0
/ Nature. (1997)10.1038/40657
/ Nature. (1997)10.4049/jimmunol.161.6.2833
/ J. Immunol. (1998)10.1038/35074122
/ Nature. (2001)
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 26, 2002, 12:48 p.m.) |
Deposited | 2 years, 1 month ago (July 25, 2023, 7:28 a.m.) |
Indexed | 2 weeks, 6 days ago (Aug. 7, 2025, 4:57 p.m.) |
Issued | 23 years, 7 months ago (Jan. 14, 2002) |
Published | 23 years, 7 months ago (Jan. 14, 2002) |
Published Online | 23 years, 7 months ago (Jan. 14, 2002) |
Published Print | 23 years, 7 months ago (Jan. 21, 2002) |
@article{Takeda_2002, title={Critical Role for Tumor Necrosis Factor–related Apoptosis-inducing Ligand in Immune Surveillance Against Tumor Development}, volume={195}, ISSN={0022-1007}, url={http://dx.doi.org/10.1084/jem.20011171}, DOI={10.1084/jem.20011171}, number={2}, journal={The Journal of Experimental Medicine}, publisher={Rockefeller University Press}, author={Takeda, Kazuyoshi and Smyth, Mark J. and Cretney, Erika and Hayakawa, Yoshihiro and Kayagaki, Nobuhiko and Yagita, Hideo and Okumura, Ko}, year={2002}, month=jan, pages={161–169} }